Latest Breaking News On - Ghost tree capital - Page 1 : comparemela.com

Form 13F-HR Ghost Tree Capital, LLC For: Dec 31

Form 13F-HR Ghost Tree Capital, LLC For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesExchange commissionGhost tree capitalCalendar yearQuarter endedInvestment manager filingTree capitalFile numberReporting managerInformation table entry totalInformation table value total

Ambrx Biopharma (NYSE:AMAM) Earns Overweight Rating from Cantor Fitzgerald

Ambrx Biopharma (NYSE:AMAM) Earns Overweight Rating from Cantor Fitzgerald
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Sonja nelsonAmbrx biopharmaGoldman sachs groupRoyal bankAmbrx biopharma incTd asset management incCantor fitzgeraldGhost tree capitalSecurities exchange commissionHighvista strategiesFree reportModerate buyBiopharma stock downCormorant asset managementExchange commissionTree capital

Aadi Bioscience, Inc (NASDAQ:AADI) Chairman Neil Desai Sells 7,037 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the sale, the chairman now owns 1,537,543 shares of the company’s stock, […]

Knott davidm jrNeil desaiAadi bioscienceAadi bioscience incGhost tree capitalRoyal bankAadi bioscience company profileGet free reportChairman neil desaiMontreal canPoint capital managementTree capitalAadi bioscience dailyNasdaq aadiInsider tradingNsider trades

Trexquant Investment LP Makes New Investment in Alpine Immune Sciences, Inc (NASDAQ:ALPN)

Trexquant Investment LP acquired a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 42,773 shares of the biotechnology company’s stock, valued at approximately $440,000. Trexquant Investment LP owned 0.09% of […]

United statesJames paul rickeyNews ratings for alpine immune sciences dailyGhost tree capitalGreat point partnersAlpine immune sciences incRoyal bankSecurities exchange commissionAmerican international group incQuarter for alpine immune sciencesAlpine immune sciences stock performanceBerenberg bankExchange commissionMorgan stanleySg americas securitiesAlpine immune sciences

Analysts Set uniQure (NASDAQ:QURE) PT at $44 70

Shares of uniQure (NASDAQ:QURE – Get Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the stock, Marketbeat reports. Nine investment analysts have rated the stock with a buy rating. The average 1 year target price among analysts that have issued a report on the stock in […]

Ricardo dolmetschRaymond jamesQure company profileProfund advisorsGhost tree capitalSanders morris harrisFund management coRoyal bankGet free reportQure trading downFund managementAsset managementMorris harrisTree capitalQure companyGet free